With frequent urge to urinate, the bladder muscles contract involuntarily, so in some cases medication is used to relax them. Studies have shown a success rate of 50%. These drugs include disiclomine (bentyl), flavoxate (urispas), imipramine (tofranil, jaminimine), oxybutynin (ditropan) and propantelin (probantin). They significantly reduce the severity of urge to urinate.
Unfortunately, the side effects of the drugs are quite significant and sometimes even dangerous; dry mouth, dry eyes, constipation, dizziness, confusion, heartburn, palpitations, lack of vision ("shrouds" in front of the eyes) are observed. If the effects of these drugs are severe, the bladder muscles may contract very infrequently, which can lead to urinary retention, i.e. the inability of the bladder to empty.
Treatment can probably start with one of the medicines listed and then, depending on the body's response, change the dosage or switch to other medicines. The main task of the doctor is to find the most effective drug in your case and to determine the exact dosage, which can significantly reduce the severity of urge to urinate with acceptable side effects.
Infectious diseases themselves rarely lead to urinary incontinence, but bladder inflammation due to infection increases the frequency of urge to urinate sharply, and the constant dripping of urine due to overflow of the bladder creates a favourable environment for the development of infection. In this case, antibiotics are prescribed as part of the general treatment regimen.
Antibiotics are usually prescribed in tablets or capsules for a short period of time, i.e. until the infection has been completely suppressed. To ensure this, the doctor takes a urine culture for examination. In some patients, however, the infection is chronic, so the antibiotic treatment is repeated or a longer course with a reduced dosage is prescribed. In acute cases, antibiotics are given intravenously. Usually the side effects of antibiotics when taken for short periods are mild: gastrointestinal upset, dizziness, fatigue, which disappear completely after the end of treatment.
What is Uripas, and how is it used?
The Urispas generic name: Flavoxat hydrochloride tablets.
Flavoxat reduces muscle spasms in the bladder and urinary tract.
Flavoxate is used to treat bladder symptoms such as painful urination, frequent or urgent urination, increased nocturnal urination, bladder pain and urinary incontinence (urinary leakage). These bladder symptoms are often caused by an overactive bladder, enlarged prostate, bladder infections or irritation of the urethra.
Flavoxate will not treat a bladder infection. Infections must be treated with an antibiotic
Uripas is in a class of drugs called antispasmodics, a urinary aid.
Urispas tablets contain flavoxate hydrochloride, a synthetic urinary tract antispasmodic.
Chemically, flavoxate hydrochloride is a hydrochloride of 2-piperidinoethyl-3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate.
Urispas is available in tablets for oral administration. Each round white film-coated tablet of Urispas has the product name and contains 100 mg of flavoxate hydrochloride. The inactive ingredients consist of calcium phosphate, hypromellose, magnesium stearate, polyethylene glycol, starch and talc.
What is flavoxate hydrochloride, and how is it used?
Flavoxate is used to treat bladder symptoms such as frequent urination, urgent urination, frequent nocturnal urination, bladder pain and urine leakage.
Indications and dosage
Uripas is indicated for relief of symptoms of dysuria, urgency, nicturia, suprapubic pain, urinary frequency and incontinence, as in cystitis, prostatitis, urethritis, urethrocystitis / urethrotrigonitis. Urispas is not indicated for definitive treatment, but is compatible with medicines used to treat urinary tract infections. Urispas relieves the symptoms of the infection and should be taken together with the antibiotic that treats the infection itself.
You should not use Flavoxat if you have bleeding or blockage of the digestive tract (stomach or bowel), blockage of the bladder or inability to urinate.
Dosage and administration
One or two 100 mg tablets 3 or 4 times daily. The dose may be reduced if symptoms improve. This drug should not be recommended for infants and children under 12 years of age because safety and efficacy have not been demonstrated in this age group.
However, if the symptoms are particularly bothersome at night, it is advisable to take a fourth film-coated tablet before bedtime. If the symptoms improve, the dose can be reduced.
Do not change the prescribed dose yourself. If you think the medicine is too weak or too strong, talk to your doctor or pharmacist.
Uripas is contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive bowel or ileum, achalasia, gastrointestinal haemorrhage and obstructive lower urinary tract uropathy.
What side effects can Urispas have?
The following side effects may occur when taking Urispas:
- Urispas may cause constipation, diarrhoea, nausea, vomiting, dry mouth, headache, hives, dizziness, palpitations, vision problems and tiredness. Allergic reactions such as rashes and itching may also occur.
If you notice any side effects that are not described here, you should tell your doctor or pharmacist.
What should also be noted?
This medicine should be stored at room temperature (15-25 °C) and out of the reach of children. Uripas has no effect on the colour of your urine and faeces.
The medicine should only be used up to the date written on the package. When you have finished treatment, return any remaining coated tablets to your doctor or pharmacist for professional disposal.
Your doctor or pharmacist will give you more information.